NasdaqGS - Delayed Quote • USD
PTC Therapeutics, Inc. (PTCT)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:44 PM EDT
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
PTCT240517C00026000 | 4/18/2024 7:29 PM | 26 | 3.50 | 2.75 | 3.80 | 2.10 | 150.00% | 1 | 1 | 64.75% |
PTCT240517C00027000 | 3/27/2024 7:45 PM | 27 | 4.27 | 1.85 | 2.85 | 0.00 | 0.00% | 10 | 10 | 53.81% |
PTCT240517C00028000 | 4/24/2024 5:59 PM | 28 | 0.75 | 1.25 | 3.50 | 0.00 | 0.00% | 15 | 421 | 76.86% |
PTCT240517C00029000 | 4/26/2024 2:59 PM | 29 | 1.25 | 0.90 | 3.30 | 0.55 | 78.57% | 1 | 10 | 83.98% |
PTCT240517C00030000 | 4/26/2024 3:03 PM | 30 | 1.07 | 0.45 | 2.95 | 0.47 | 78.33% | 12 | 15 | 83.89% |
PTCT240517C00031000 | 4/22/2024 5:24 PM | 31 | 0.40 | 0.40 | 2.60 | 0.00 | 0.00% | 5 | 12 | 89.06% |
PTCT240517C00032000 | 4/18/2024 6:17 PM | 32 | 0.30 | 0.20 | 3.00 | 0.00 | 0.00% | - | 4 | 104.20% |
PTCT240517C00036000 | 4/3/2024 7:07 PM | 36 | 0.05 | 0.05 | 3.10 | -0.74 | -93.67% | 2 | 3 | 140.72% |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
---|---|---|---|---|---|---|---|---|---|---|
PTCT240517P00028000 | 3/27/2024 4:20 PM | 28 | 2.20 | 0.45 | 4.50 | 0.00 | 0.00% | 13 | 13 | 101.86% |
PTCT240517P00029000 | 3/27/2024 7:45 PM | 29 | 2.50 | 1.05 | 3.90 | 0.00 | 0.00% | 15 | 15 | 81.93% |
PTCT240517P00030000 | 3/19/2024 7:23 PM | 30 | 3.10 | 5.10 | 6.80 | 0.00 | 0.00% | 12 | 12 | 187.30% |
Related Tickers
RARE Ultragenyx Pharmaceutical Inc.
44.24
+0.89%
CGON CG Oncology, Inc.
41.00
+13.26%
AGIO Agios Pharmaceuticals, Inc.
31.49
-0.57%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
BPMC Blueprint Medicines Corporation
93.00
+2.50%
SAGE Sage Therapeutics, Inc.
13.69
+0.81%
ALNY Alnylam Pharmaceuticals, Inc.
143.31
-0.28%
VERA Vera Therapeutics, Inc.
39.65
+2.48%
SRPT Sarepta Therapeutics, Inc.
128.77
+1.08%
APGE Apogee Therapeutics, Inc.
47.13
+2.77%